copy of dr. brahmer on immunotherapy in stage iv nsclc
Published 6 years ago • 16 plays • Length 0:19Download video MP4
Download video MP3
Similar videos
-
1:14
dr. brahmer on immunotherapy in stage iv nsclc
-
0:31
copy of dr. brahmer on the role of immunotherapy in metastatic nsclc
-
1:31
dr. brahmer on the role of immunotherapy in metastatic nsclc
-
1:33
dr. chaft on the emergence of immunotherapy in stage iv lung cancer
-
1:25
dr. brahmer on chemoimmunotherapy in patients with nsclc
-
1:32
dr. brahmer on the benefit of immunotherapy in metastatic nsclc
-
1:15
dr. brahmer on immunotherapy beyond pd-1/l1 in nsclc
-
1:29
dr. brahmer on managing immune-related aes in lung cancer
-
1:18
dr. brahmer on 5-year follow-up data for nivolumab in nsclc
-
0:58
dr. julie r. brahmer on immunotherapy development in lung cancer
-
1:48
dr. brahmer discusses frontline single-agent pembrolizumab in lung cancer
-
1:41
dr. brahmer discusses second-line pembrolizumab in nsclc
-
1:23
dr. brahmer on biomarkers for immune response in nsclc
-
1:54
dr. brahmer on impact of checkmate-057 in nsclc
-
1:59
dr. brahmer on side effects of immunotherapy for lung cancer
-
1:25
dr. brahmer discusses response to immunotherapy
-
1:10
dr. patel on immunotherapy landscape of stage iv nsclc
-
1:05
dr. brahmer on the impower150 trial in nsclc
-
1:05
dr. sampath on safety of immunotherapy plus radiation in lung cancer